{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:02:26Z","timestamp":1794628946323,"version":"4.9.1"},"reference-count":182,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Aromatase inhibitors (AIs), with or without gonadotropin-releasing hormone analogs, are the cornerstone of adjuvant endocrine therapy for women with hormone receptor-positive early-stage breast cancer, offering significant reductions in recurrence risk and improving long-term survival. Their use is frequently accompanied by treatment-related toxicities that can adversely affect patients\u2019 quality of life (QoL) and adherence to therapy. Commonly reported side effects include vasomotor symptoms, such as hot flashes; musculoskeletal disorders, such as arthralgia and myalgia; mood disorders; and genitourinary discomfort, such as vaginal dryness and dyspareunia. Additionally, AIs are associated with a heightened risk of bone loss, leading to osteoporosis and fractures, and may have implications for cardiovascular health. Effective management of these adverse events is pivotal in maintaining treatment adherence and preserving QoL. Evidence-based strategies to address these toxicities include pharmacological interventions, such as analgesics for joint pain, bisphosphonates or denosumab for bone health, and hormonal or non-hormonal approaches for vasomotor and genitourinary symptoms. Non-pharmacological measures, including physical activity, dietary adjustments, and complementary therapies, can also help mitigate symptoms. This review examines the broad spectrum of AI-associated toxicities, discusses their clinical implications, and provides an overview of evidence-based management strategies. These insights aim to support clinicians in optimizing patient care while minimizing the toxicities of therapy.<\/jats:p>","DOI":"10.3390\/cancers17172726","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T11:50:31Z","timestamp":1755863431000},"page":"2726","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6150-5895","authenticated-orcid":false,"given":"Simone","family":"Nardin","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, Maggiore University Hospital, 28100 Novara, Italy"},{"name":"Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, 16126 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8405-7256","authenticated-orcid":false,"given":"Beatrice","family":"Ruffilli","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Maggiore University Hospital, 28100 Novara, Italy"},{"name":"Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9892-6388","authenticated-orcid":false,"given":"Tommaso Lupo","family":"Landolfo","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Maggiore University Hospital, 28100 Novara, Italy"},{"name":"Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1772-8734","authenticated-orcid":false,"given":"Giulia","family":"Isingrini","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Maggiore University Hospital, 28100 Novara, Italy"},{"name":"Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7160-8812","authenticated-orcid":false,"given":"Ida","family":"Taglialatela","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Maggiore University Hospital, 28100 Novara, Italy"},{"name":"Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Delbarba","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, SSD of Endocrinology, ASST Spedali Civili of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"D\u2019Avanzo","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Maggiore University Hospital, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Rossi","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Maggiore University Hospital, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4170-9396","authenticated-orcid":false,"given":"Eduardo","family":"Celentano","sequence":"additional","affiliation":[{"name":"Department of Electrophysiology, Humanitas Gavazzeni, Via Mauro Gavazzeni 21, 24125 Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Conte","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Maggiore University Hospital, 28100 Novara, Italy"},{"name":"Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Nardin","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele-Milan, Italy"},{"name":"Internal Medicine, Department of Medicine, ASST Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Gennari","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Maggiore University Hospital, 28100 Novara, Italy"},{"name":"Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA","volume":"71","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO\/CAP Guideline Update","volume":"38","author":"Allison","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast Cancer Treatment","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1470-2045(21)00758-0","article-title":"Aromatase Inhibitors versus Tamoxifen in Premenopausal Women with Oestrogen Receptor-Positive Early-Stage Breast Cancer Treated with Ovarian Suppression: A Patient-Level Meta-Analysis of 7030 Women from Four Randomised Trials","volume":"23","author":"Bradley","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG) (2015). Aromatase Inhibitors versus Tamoxifen in Early Breast Cancer: Patient-Level Meta-Analysis of the Randomised Trials. Lancet, 386, 1341\u20131352.","DOI":"10.1016\/S0140-6736(15)61074-1"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.22.01064","article-title":"Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials","volume":"41","author":"Pagani","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"105057","DOI":"10.1016\/j.esmoop.2025.105057","article-title":"Extended Adjuvant Endocrine Therapy in Early Breast Cancer: Finding the Individual Balance","volume":"10","author":"Arecco","year":"2025","journal-title":"ESMO Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early Breast Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1016\/S1470-2045(20)30666-5","article-title":"Evidence-Based Approaches for the Management of Side-Effects of Adjuvant Endocrine Therapy in Patients with Breast Cancer","volume":"22","author":"Franzoi","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1200\/JCO.19.01758","article-title":"Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk","volume":"38","author":"Pistilli","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1470-2045(15)00049-2","article-title":"Patient-Reported Outcomes with Adjuvant Exemestane versus Tamoxifen in Premenopausal Women with Early Breast Cancer Undergoing Ovarian Suppression (TEXT and SOFT): A Combined Analysis of Two Phase 3 Randomised Trials","volume":"16","author":"Bernhard","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1200\/JCO.2011.38.0261","article-title":"Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer","volume":"30","author":"Henry","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-012-2114-5","article-title":"Adherence to Adjuvant Hormonal Therapy among Breast Cancer Survivors in Clinical Practice: A Systematic Review","volume":"134","author":"Murphy","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"134920","DOI":"10.1016\/j.molstruc.2023.134920","article-title":"New Imidazole Derivatives as Aromatase Inhibitor: Design, Synthesis, Biological Activity, Molecular Docking, and Computational ADME-Tox Studies","volume":"1278","author":"Celik","year":"2023","journal-title":"J. Mol. Struct."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbapap.2010.06.021","article-title":"At the Crossroads of Steroid Hormone Biosynthesis: The Role, Substrate Specificity and Evolutionary Development of CYP17","volume":"1814","author":"Gilep","year":"2011","journal-title":"Biochim. Biophys. Acta\u2014Proteins Proteomics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature07614","article-title":"Structural Basis for Androgen Specificity and Oestrogen Synthesis in Human Aromatase","volume":"457","author":"Ghosh","year":"2009","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsbmb.2011.02.001","article-title":"Aromatase, Aromatase Inhibitors, and Breast Cancer","volume":"125","author":"Chumsri","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0093-7754(03)00302-6","article-title":"Aromatase Inhibitors: Mechanism of Action and Role in the Treatment of Breast Cancer","volume":"30","author":"Miller","year":"2003","journal-title":"Semin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/sj.bjc.6602688","article-title":"Role of Aromatase Inhibitors in Breast Cancer","volume":"93","author":"Carpenter","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/jamaoncol.2023.0089","article-title":"Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor\u2013Positive Breast Cancer","volume":"9","author":"Serrano","year":"2023","journal-title":"JAMA Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1586\/14737140.2.2.181","article-title":"Aromatase Inhibitors in Breast Cancer Therapy","volume":"2","author":"Brueggemeier","year":"2002","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10549-017-4346-x","article-title":"Variable Aromatase Inhibitor Plasma Concentrations Do Not Correlate with Circulating Estrogen Concentrations in Post-Menopausal Breast Cancer Patients","volume":"165","author":"Hertz","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jsbmb.2013.08.010","article-title":"Menopausal Hot Flashes: Mechanisms, Endocrinology, Treatment","volume":"142","author":"Freedman","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5122(00)00151-1","article-title":"The Role of Serotonin in Hot Flushes","volume":"36","author":"Berendsen","year":"2000","journal-title":"Maturitas"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-007-9774-6","article-title":"Prospective Characterization of Musculoskeletal Symptoms in Early Stage Breast Cancer Patients Treated with Aromatase Inhibitors","volume":"111","author":"Henry","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/cncr.24419","article-title":"Patterns and Risk Factors Associated with Aromatase Inhibitor-related Arthralgia among Breast Cancer Survivors","volume":"115","author":"Mao","year":"2009","journal-title":"Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1200\/JCO.2007.10.7573","article-title":"Prevalence of Joint Symptoms in Postmenopausal Women Taking Aromatase Inhibitors for Early-Stage Breast Cancer","volume":"25","author":"Crew","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/cam4.1256","article-title":"Genomic Risk Prediction of Aromatase Inhibitor-Related Arthralgia in Patients with Breast Cancer Using a Novel Machine-Learning Algorithm","volume":"7","author":"Reinbolt","year":"2018","journal-title":"Cancer Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.critrevonc.2008.07.013","article-title":"Aromatase Inhibitor-Associated Bone Loss in Breast Cancer Patients Is Distinct from Postmenopausal Osteoporosis","volume":"69","author":"Hadji","year":"2009","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/annonc\/mds277","article-title":"Zoledronic Acid (Zoledronate) for Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole (ZO-FAST Study): Final 60-Month Results","volume":"24","author":"Coleman","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1470-2045(18)30862-3","article-title":"Adjuvant Denosumab in Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer (ABCSG-18): Disease-Free Survival Results from a Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial","volume":"20","author":"Gnant","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.ajog.2005.04.001","article-title":"Body Mass, Estrogen Levels, and Hot Flashes in Midlife Women","volume":"193","author":"Gallicchio","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.mayocp.2017.08.019","article-title":"Genitourinary Syndrome of Menopause: Management Strategies for the Clinician","volume":"92","author":"Faubion","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e19522","DOI":"10.1200\/jco.2010.28.15_suppl.e19522","article-title":"Improving Sexual Function in Female Cancer Survivors: A Systematic Review of Psychosocial Interventions","volume":"28","author":"Revenson","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.breast.2010.03.025","article-title":"Cognitive Function in Postmenopausal Women Receiving Adjuvant Letrozole or Tamoxifen for Breast Cancer in the BIG 1-98 Randomized Trial","volume":"19","author":"Phillips","year":"2010","journal-title":"The Breast"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/gme.0b013e318148b28b","article-title":"Memory Impairments with Adjuvant Anastrozole versus Tamoxifen in Women with Early-Stage Breast Cancer","volume":"14","author":"Bender","year":"2007","journal-title":"Menopause"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jpainsymman.2016.09.011","article-title":"Fatigue During and After Breast Cancer Therapy\u2014A Prospective Study","volume":"53","author":"Reinertsen","year":"2017","journal-title":"J. Pain Symptom Manage."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","article-title":"Cancer-Related Fatigue\u2014Mechanisms, Risk Factors, and Treatments","volume":"11","author":"Bower","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jnci\/djr242","article-title":"Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-Analysis","volume":"103","author":"Amir","year":"2011","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"B\u00e9rczi, B., Farkas, N., Hegyi, P., T\u00f3th, B., Csupor, D., N\u00e9meth, B., Luk\u00e1cs, A., Czumbel, L.M., Ker\u00e9mi, B., and Kiss, I. (2024). Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis. J. Clin. Med., 13.","DOI":"10.3390\/jcm13061818"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"(2005). ATAC Trialists\u2019 Group Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial after Completion of 5 Years\u2019 Adjuvant Treatment for Breast Cancer. Lancet, 365, 60\u201362.","DOI":"10.1016\/S0140-6736(04)17666-6"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(11)70364-3","article-title":"Cognitive Behavioural Treatment for Women Who Have Menopausal Symptoms after Breast Cancer Treatment (MENOS 1): A Randomised Controlled Trial","volume":"13","author":"Mann","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2012.41.8525","article-title":"Efficacy of Cognitive Behavioral Therapy and Physical Exercise in Alleviating Treatment-Induced Menopausal Symptoms in Patients With Breast Cancer: Results of a Randomized, Controlled, Multicenter Trial","volume":"30","author":"Duijts","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4103\/0973-1482.183174","article-title":"Acupuncture for the Relief of Hot Flashes in Breast Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies","volume":"14","author":"Wang","year":"2018","journal-title":"J. Cancer Res. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1543938","DOI":"10.3389\/fonc.2025.1543938","article-title":"How Effective Is Acupuncture in Treating Hot Flashes in Breast Cancer Patients? A Systematic Review and Meta-Analysis","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e0180918","DOI":"10.1371\/journal.pone.0180918","article-title":"Effect of Acupuncture on Hot Flush and Menopause Symptoms in Breast Cancer- A Systematic Review and Meta-Analysis","volume":"12","author":"Chien","year":"2017","journal-title":"PLoS One"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1543735420940394","DOI":"10.1177\/1534735420940394","article-title":"Acupuncture for Hormone Therapy\u2013Related Side Effects in Breast Cancer Patients: A GRADE-Assessed Systematic Review and Updated Meta-Analysis","volume":"19","author":"Yuanqing","year":"2020","journal-title":"Integr. Cancer Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2009.23.5150","article-title":"Acupuncture Versus Venlafaxine for the Management of Vasomotor Symptoms in Patients With Hormone Receptor\u2013Positive Breast Cancer: A Randomized Controlled Trial","volume":"28","author":"Walker","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in Management of Hot Flashes in Survivors of Breast Cancer: A Randomised Controlled Trial","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1634\/theoncologist.12-1-124","article-title":"Randomized, Double-Blind, Placebo-Controlled Crossover Trials of Venlafaxine for Hot Flashes After Breast Cancer","volume":"12","author":"Carpenter","year":"2007","journal-title":"Oncologist"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10549-008-0138-7","article-title":"Venlafaxine versus Clonidine for the Treatment of Hot Flashes in Breast Cancer Patients: A Double-Blind, Randomized Cross-over Study","volume":"115","author":"Buijs","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","article-title":"Gabapentin for Hot Flashes in 420 Women with Breast Cancer: A Randomised Double-Blind Placebo-Controlled Trial","volume":"366","author":"Pandya","year":"2005","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2053369118824920","article-title":"British Menopause Society Consensus Statement on the Management of Estrogen Deficiency Symptoms, Arthralgia and Menopause Diagnosis in Women Treated for Early Breast Cancer","volume":"25","author":"Marsden","year":"2019","journal-title":"Post Reprod. Heal."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10549-010-0802-6","article-title":"Weight Gain Is Associated with Increased Risk of Hot Flashes in Breast Cancer Survivors on Aromatase Inhibitors","volume":"124","author":"Su","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/aje\/kwp203","article-title":"Gains in Body Fat and Vasomotor Symptom Reporting Over the Menopausal Transition: The Study of Women\u2019s Health Across the Nation","volume":"170","author":"Thurston","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0140-6736(23)00085-5","article-title":"Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Associated with Menopause (SKYLIGHT 1): A Phase 3 Randomised Controlled Study","volume":"401","author":"Lederman","year":"2023","journal-title":"Lancet"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa2415566","article-title":"Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer","volume":"393","author":"Cardoso","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1200\/JCO.2008.16.6389","article-title":"Randomized Trial of a Hypnosis Intervention for Treatment of Hot Flashes Among Breast Cancer Survivors","volume":"26","author":"Elkins","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e003138","DOI":"10.1136\/bmjopen-2013-003138","article-title":"Randomised Controlled Trial Comparing Hypnotherapy versus Gabapentin for the Treatment of Hot Flashes in Breast Cancer Survivors: A Pilot Study","volume":"3","author":"Salzillo","year":"2013","journal-title":"BMJ Open"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/annonc\/mdr478","article-title":"Stellate Ganglion Block for the Management of Hot Flashes and Sleep Disturbances in Breast Cancer Survivors: An Uncontrolled Experimental Study with 24 Weeks of Follow-Up","volume":"23","author":"Haest","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.2147\/CMAR.S173511","article-title":"Comparison of the Effects of Stellate Ganglion Block and Paroxetine on Hot Flashes and Sleep Disturbance in Breast Cancer Survivors","volume":"10","author":"Rahimzadeh","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1200\/JCO.2014.57.1547","article-title":"Randomized Exercise Trial of Aromatase Inhibitor\u2013Induced Arthralgia in Breast Cancer Survivors","volume":"33","author":"Irwin","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_63","first-page":"244","article-title":"Aerobic Exercise and Aromatase Inhibitor\u2013Associated Musculoskeletal Symptoms: Results of a Randomized Clinical Trial","volume":"33","author":"Bender","year":"2025","journal-title":"Support. Care Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1534735411413270","article-title":"Impact of Yoga on Functional Outcomes in Breast Cancer Survivors With Aromatase Inhibitor\u2013Associated Arthralgias","volume":"11","author":"Galantino","year":"2012","journal-title":"Integr. Cancer Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.2017.74.6651","article-title":"Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor\u2013Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202","volume":"36","author":"Henry","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10549-011-1644-6","article-title":"Vitamin D and Aromatase Inhibitor-Induced Musculoskeletal Symptoms (AIMSS): A Phase II, Double-Blind, Placebo-Controlled, Randomized Trial","volume":"129","author":"Rastelli","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10549-017-4429-8","article-title":"Randomized Trial of Vitamin D3 to Prevent Worsening of Musculoskeletal Symptoms in Women with Breast Cancer Receiving Adjuvant Letrozole. The VITAL Trial","volume":"166","author":"Khan","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10549-016-3710-6","article-title":"Randomized, Blinded Trial of Vitamin D3 for Treating Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS)","volume":"155","author":"Shapiro","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/jco.2016.34.3_suppl.158","article-title":"Crossover from One Aromatase Inhibitor (AI) to Another in the Exemestane and Letrozole Pharmacogenetics (ELPh) Trial","volume":"34","author":"Kadakia","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1200\/JCO.2014.59.5595","article-title":"Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor\u2013Induced Musculoskeletal Pain: SWOG S0927","volume":"33","author":"Hershman","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-018-4946-0","article-title":"Omega-3 Fatty Acid Use for Obese Breast Cancer Patients with Aromatase Inhibitor-Related Arthralgia (SWOG S0927)","volume":"172","author":"Shen","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-009-0332-2","article-title":"Immediate versus Delayed Zoledronic Acid for Prevention of Bone Loss in Postmenopausal Women with Breast Cancer Starting Letrozole after Tamoxifen-N03CC","volume":"117","author":"Hines","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/j.seminoncol.2006.03.022","article-title":"Management of Cancer-Treatment\u2013Induced Bone Loss in Postmenopausal Women Undergoing Adjuvant Breast Cancer Therapy: A Z-FAST Update","volume":"33","author":"Brufsky","year":"2006","journal-title":"Semin. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","article-title":"Adjuvant Denosumab in Breast Cancer (ABCSG-18): A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial","volume":"386","author":"Gnant","year":"2015","journal-title":"Lancet"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14737140.2016.1192466","article-title":"Denosumab versus Zoledronic Acid to Prevent Aromatase Inhibitors-Associated Fractures in Postmenopausal Early Breast Cancer; a Mixed Treatment Meta-Analysis","volume":"16","year":"2016","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","article-title":"Bone Health in Cancer: ESMO Clinical Practice Guidelines","volume":"31","author":"Coleman","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_77","first-page":"CD008729","article-title":"Psychological Interventions for Women with Non-Metastatic Breast Cancer","volume":"1","author":"Jassim","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1002\/cncr.28917","article-title":"Electroacupuncture for Fatigue, Sleep, and Psychological Distress in Breast Cancer Patients with Aromatase Inhibitor-related Arthralgia: A Randomized Trial","volume":"120","author":"Mao","year":"2014","journal-title":"Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1002\/cncr.26230","article-title":"Pilot Study of Duloxetine for Treatment of Aromatase Inhibitor-associated Musculoskeletal Symptoms","volume":"117","author":"Henry","year":"2011","journal-title":"Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00404-023-07323-y","article-title":"Safety and Efficacy of Non-Ablative CO2 Laser Treatment of Vulvo-Vaginal Atrophy in Women with History of Breast Cancer","volume":"309","author":"Lami","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jsxm.2021.01.188","article-title":"A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause","volume":"18","author":"Cruff","year":"2021","journal-title":"J. Sex. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/13697137.2023.2167596","article-title":"Vaginal Oxygen plus Hyaluronic Acid on Genito-Urinary Symptoms of Breast Cancer Survivors","volume":"26","author":"Massarotti","year":"2023","journal-title":"Climacteric"},{"key":"ref_83","first-page":"311","article-title":"A Single-Arm, Prospective Trial Investigating the Effectiveness of a Non-Hormonal Vaginal Moisturizer Containing Hyaluronic Acid in Postmenopausal Cancer Survivors","volume":"29","author":"Carter","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13058-024-01886-7","article-title":"Safety and Efficacy of Topical Testosterone in Breast Cancer Patients Receiving Ovarian Suppression and Aromatase Inhibitor Therapy","volume":"26","author":"Taranto","year":"2024","journal-title":"Breast Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2014.60.7366","article-title":"A Practical Solution for Dyspareunia in Breast Cancer Survivors: A Randomized Controlled Trial","volume":"33","author":"Goetsch","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/09513591003632258","article-title":"Low-Dose Vaginal Estrogens or Vaginal Moisturizer in Breast Cancer Survivors with Urogenital Atrophy: A Preliminary Study","volume":"26","author":"Biglia","year":"2010","journal-title":"Gynecol. Endocrinol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/jamaoncol.2023.4508","article-title":"Vaginal Estrogen Therapy Use and Survival in Females With Breast Cancer","volume":"10","author":"McVicker","year":"2024","journal-title":"JAMA Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-012-2198-y","article-title":"Local Estrogen Therapy and Risk of Breast Cancer Recurrence among Hormone-Treated Patients: A Nested Case\u2013Control Study","volume":"135","author":"Bonnetain","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-024-07564-8","article-title":"Effects of Vaginal Estrogen on Serum Estradiol during Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: A Prospective Trial","volume":"210","author":"Vehmanen","year":"2025","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/gme.0b013e318279ba64","article-title":"Ospemifene, a Novel Selective Estrogen Receptor Modulator for Treating Dyspareunia Associated with Postmenopausal Vulvar and Vaginal Atrophy","volume":"20","author":"Portman","year":"2013","journal-title":"Menopause"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.maturitas.2020.06.021","article-title":"No Increase in Incidence or Risk of Recurrence of Breast Cancer in Ospemifene-Treated Patients with Vulvovaginal Atrophy (VVA)","volume":"142","author":"Cai","year":"2020","journal-title":"Maturitas"},{"key":"ref_92","first-page":"784","article-title":"Resistance Training Improves Fatigue and Quality of Life in Previously Sedentary Breast Cancer Survivors: A Randomised Controlled Trial","volume":"25","author":"Hagstrom","year":"2016","journal-title":"Eur. J. Cancer Care"},{"key":"ref_93","first-page":"1047","article-title":"Sustainable Impact of an Individualized Exercise Program on Physical Activity Level and Fatigue Syndrome on Breast Cancer Patients in Two German Rehabilitation Centers","volume":"25","author":"Baumann","year":"2017","journal-title":"Support. Care Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Cramp, F., and Byron-Daniel, J. (2012). Exercise for the Management of Cancer-Related Fatigue in Adults. Cochrane Database Syst. Rev., 2012.","DOI":"10.1002\/14651858.CD006145.pub3"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/cncr.29330","article-title":"Yoga and Meditation for Menopausal Symptoms in Breast Cancer Survivors\u2014A Randomized Controlled Trial","volume":"121","author":"Cramer","year":"2015","journal-title":"Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e36468","DOI":"10.1097\/MD.0000000000036468","article-title":"Effect of Yoga on Cancer-Related Fatigue in Patients with Breast Cancer: A Systematic Review and Meta-Analysis","volume":"103","author":"Hou","year":"2024","journal-title":"Medicine"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1435110","DOI":"10.3389\/fpsyg.2024.1435110","article-title":"Effect of Cognitive-Behavioral Therapy on Fatigue in Cancer Patients: A Systematic Review and Meta-Analysis","volume":"15","author":"Karimy","year":"2025","journal-title":"Front. Psychol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.annonc.2019.09.002","article-title":"Cognitive Behavioral Therapy or Graded Exercise Therapy Compared with Usual Care for Severe Fatigue in Patients with Advanced Cancer during Treatment: A Randomized Controlled Trial","volume":"31","author":"Poort","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/sj.bjc.6603899","article-title":"Cognitive Behaviour Therapy for Fatigued Cancer Survivors: Long-Term Follow-Up","volume":"97","author":"Gielissen","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1001\/jamaoncol.2016.1867","article-title":"Investigation of 2 Types of Self-Administered Acupressure for Persistent Cancer-Related Fatigue in Breast Cancer Survivors","volume":"2","author":"Zick","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Yennurajalingam, S., Lu, Z., Rozman De Moraes, A., Tull, N.N., Kubiak, M.J., Geng, Y., Andersen, C.R., and Bruera, E. (2022). Meta-Analysis of Pharmacological, Nutraceutical and Phytopharmaceutical Interventions for the Treatment of Cancer Related Fatigue. Cancers, 15.","DOI":"10.3390\/cancers15010091"},{"key":"ref_102","first-page":"CD015118","article-title":"Pharmacological Interventions to Treat Adults with Cancer-Related Fatigue","volume":"2023","author":"Andreas","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/bjc.2014.171","article-title":"Effects of Erythropoiesis-Stimulating Agents on Fatigue- and Anaemia-Related Symptoms in Cancer Patients: Systematic Review and Meta-Analyses of Published and Unpublished Data","volume":"111","author":"Bohlius","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_104","first-page":"4437","article-title":"Vasomotor Symptoms in Early Breast Cancer\u2014A \u201cReal World\u201d Exploration of the Patient Experience","volume":"30","author":"Cole","year":"2022","journal-title":"Support. Care Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3747\/co.v17i1.473","article-title":"Management of Hot Flashes in Women with Breast Cancer","volume":"17","author":"Kligman","year":"2010","journal-title":"Curr. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5694\/mja16.00947","article-title":"Supportive Care of Women with Breast Cancer: Key Concerns and Practical Solutions","volume":"205","author":"Zdenkowski","year":"2016","journal-title":"Med. J. Aust."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1210\/jc.2017-01138","article-title":"Managing Menopausal Symptoms and Associated Clinical Issues in Breast Cancer Survivors","volume":"102","author":"Santen","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11912-021-01055-5","article-title":"Managing Common Estrogen Deprivation Side Effects in HR+ Breast Cancer: An Evidence-Based Review","volume":"23","author":"Bordignon","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.maturitas.2012.07.010","article-title":"The Management of Menopausal Symptoms in Breast Cancer Survivors: A Case-Based Approach","volume":"73","author":"Lammerink","year":"2012","journal-title":"Maturitas"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1200\/JCO.2011.36.8597","article-title":"Effect of Postdiagnosis Weight Change on Hot Flash Status Among Early-Stage Breast Cancer Survivors","volume":"30","author":"Caan","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/01.gme.0000185754.85328.44","article-title":"Dietary Factors and Vasomotor Symptoms in Breast Cancer Survivors","volume":"13","author":"Gold","year":"2006","journal-title":"Menopause"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"102241","DOI":"10.1016\/j.esmoop.2024.102241","article-title":"Body Mass Index, Weight Change, and Cancer Prognosis: A Meta-Analysis and Systematic Review of 73 Cohort Studies","volume":"9","author":"Wen","year":"2024","journal-title":"ESMO Open"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ijc.34322","article-title":"Postdiagnosis Body Fatness, Weight Change and Breast Cancer Prognosis: Global Cancer Update Program (CUP Global) Systematic Literature Review and Meta-analysis","volume":"152","author":"Chan","year":"2023","journal-title":"Int. J. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/NCC.0000000000000827","article-title":"Cognitive-Behavioral Therapy to Alleviate Treatment-Induced Menopausal Symptoms in Women With Breast Cancer","volume":"44","author":"Chang","year":"2021","journal-title":"Cancer Nurs."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.maturitas.2017.12.005","article-title":"Yoga for Menopausal Symptoms\u2014A Systematic Review and Meta-Analysis","volume":"109","author":"Cramer","year":"2018","journal-title":"Maturitas"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"(2022). The North American Menopause Society The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause, 29, 767\u2013794.","DOI":"10.1097\/GME.0000000000002028"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"(2015). The North American Menopause Society Nonhormonal Management of Menopause-Associated Vasomotor Symptoms. Menopause, 22, 1155\u20131174.","DOI":"10.1097\/GME.0000000000000546"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.maturitas.2005.01.001","article-title":"Evaluation of Low-Dose Venlafaxine Hydrochloride for the Therapy of Hot Flushes in Breast Cancer Survivors","volume":"52","author":"Biglia","year":"2005","journal-title":"Maturitas"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-132-10-200005160-00004","article-title":"Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Oncology Program Study","volume":"132","author":"Pandya","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1200\/JCO.2010.29.9230","article-title":"Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors","volume":"28","author":"Bordeleau","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"pkz088","DOI":"10.1093\/jncics\/pkz088","article-title":"Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603)","volume":"4","author":"Novotny","year":"2020","journal-title":"JNCI Cancer Spectr."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2012.07.003","article-title":"Hormone Replacement Therapy after Breast Cancer: 10 Year Follow up of the Stockholm Randomised Trial","volume":"49","author":"Fornander","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10549-021-06436-9","article-title":"Safety of Systemic Hormone Replacement Therapy in Breast Cancer Survivors: A Systematic Review and Meta-Analysis","volume":"191","author":"Poggio","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.2017.75.8995","article-title":"Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline","volume":"36","author":"Carter","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1200\/OP.20.00113","article-title":"Management of Aromatase Inhibitor\u2013Induced Musculoskeletal Symptoms","volume":"16","author":"Gupta","year":"2020","journal-title":"JCO Oncol. Pract."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10549-009-0692-7","article-title":"Effect of a Switch of Aromatase Inhibitors on Musculoskeletal Symptoms in Postmenopausal Women with Hormone-Receptor-Positive Breast Cancer: The ATOLL (Articular Tolerance of Letrozole) Study","volume":"120","author":"Briot","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.critrevonc.2017.01.010","article-title":"Management of Aromatase Inhibitor Induced Musculoskeletal Symptoms in Postmenopausal Early Breast Cancer: A Systematic Review and Meta-Analysis","volume":"111","author":"Roberts","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e19725","DOI":"10.1200\/jco.2011.29.15_suppl.e19725","article-title":"Feasibility of a Defined Exercise Program for Aromatase Inhibitor\u2013Related Arthralgia (AIRA) in Breast Cancer Survivors","volume":"29","author":"Lash","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_129","first-page":"493","article-title":"Exercise Intervention in Breast Cancer Patients with Aromatase Inhibitor-Associated Arthralgia: A Pilot Study","volume":"23","author":"DeNysschen","year":"2014","journal-title":"Eur. J. Cancer Care"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jpainsymman.2016.03.010","article-title":"Nordic Walking as an Exercise Intervention to Reduce Pain in Women With Aromatase Inhibitor\u2013Associated Arthralgia: A Feasibility Study","volume":"52","author":"Fields","year":"2016","journal-title":"J. Pain Symptom Manag."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.apmr.2012.09.008","article-title":"The Effectiveness of a Deep Water Aquatic Exercise Program in Cancer-Related Fatigue in Breast Cancer Survivors: A Randomized Controlled Trial","volume":"94","year":"2013","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/pon.3756","article-title":"Pilot Study of Iyengar Yoga for Management of Aromatase Inhibitor-Associated Arthralgia in Women with Breast Cancer","volume":"24","author":"Jacobsen","year":"2015","journal-title":"Psychooncology."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11764-007-0034-x","article-title":"Pilot Study of Acupuncture for the Treatment of Joint Symptoms Related to Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients","volume":"1","author":"Crew","year":"2007","journal-title":"J. Cancer Surviv."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2009.23.4708","article-title":"Randomized, Blinded, Sham-Controlled Trial of Acupuncture for the Management of Aromatase Inhibitor\u2013Associated Joint Symptoms in Women With Early-Stage Breast Cancer","volume":"28","author":"Crew","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jama.2018.8907","article-title":"Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer","volume":"320","author":"Hershman","year":"2018","journal-title":"JAMA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(17)30715-5","article-title":"Extended Adjuvant Intermittent Letrozole versus Continuous Letrozole in Postmenopausal Women with Breast Cancer (SOLE): A Multicentre, Open-Label, Randomised, Phase 3 Trial","volume":"19","author":"Colleoni","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/annonc\/mdr017","article-title":"Management of Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Breast Cancer: Practical Guidance for Prevention and Treatment","volume":"22","author":"Hadji","year":"2011","journal-title":"Ann. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.2007.11.0726","article-title":"Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230","volume":"26","author":"Eastell","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13058-025-02050-5","article-title":"Aromatase Inhibitors Therapy and Major Osteoporotic Fracture Risk in Postmenopausal Breast Cancer Patients: A Nationwide Real-World Cohort Study","volume":"27","author":"Liu","year":"2025","journal-title":"Breast Cancer Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e390442","DOI":"10.1200\/EDBK_390442","article-title":"Advances in the Management of Menopausal Symptoms, Fertility Preservation, and Bone Health for Women With Breast Cancer on Endocrine Therapy","volume":"43","author":"Lambertini","year":"2023","journal-title":"Am. Soc. Clin. Oncol. Educ. B"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"154962","DOI":"10.1016\/j.metabol.2021.154962","article-title":"Effect of Antiresorptive Therapy on Aromatase Inhibitor Induced Bone Loss in Postmenopausal Women with Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"128","author":"Bassatne","year":"2022","journal-title":"Metabolism"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"(2015). Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG) Adjuvant Bisphosphonate Treatment in Early Breast Cancer: Meta-Analyses of Individual Patient Data from Randomised Trials. Lancet, 386, 1353\u20131361.","DOI":"10.1016\/S0140-6736(15)60908-4"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00198-025-07422-3","article-title":"Update on the Role of Bone Turnover Markers in the Diagnosis and Management of Osteoporosis: A Consensus Paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International","volume":"36","author":"Bhattoa","year":"2025","journal-title":"Osteoporos. Int."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S2213-8587(17)30184-5","article-title":"Use of Bone Turnover Markers in Postmenopausal Osteoporosis","volume":"5","author":"Eastell","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1803164","article-title":"Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer","volume":"379","author":"Francis","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10549-023-06981-5","article-title":"The Relationship between Anxiety and Vaginal-Related Sexual Health in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors Therapies: A Cross Sectional Study","volume":"200","author":"Bryl","year":"2023","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.23.00293","article-title":"Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update","volume":"41","author":"Andersen","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10549-016-3928-3","article-title":"Effect of Selective Serotonin Reuptake Inhibitors Use on Endocrine Therapy Adherence and Breast Cancer Mortality: A Population-Based Study","volume":"159","author":"Valachis","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.breast.2008.04.001","article-title":"The Impact of Aromatase Inhibitors on Sexual Functioning: Current Knowledge and Future Research Directions","volume":"17","author":"Mok","year":"2008","journal-title":"Breast"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3390\/curroncol29030149","article-title":"Gynecologic Symptoms among Hormone Receptor-Positive Breast Cancer Patients on Oral Endocrine Therapy: A Cross-Sectional Study","volume":"29","author":"Moskalewicz","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.maturitas.2023.02.001","article-title":"Assessing Vaginal Wall Thickness by Transvaginal Ultrasound in Breast Cancer Survivors: A Pilot Study","volume":"171","author":"Ros","year":"2023","journal-title":"Maturitas"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"7417","DOI":"10.1038\/s41598-024-58118-3","article-title":"Vaginal Microbiomes of Breast Cancer Survivors Treated with Aromatase Inhibitors with and without Vulvovaginal Symptoms","volume":"14","author":"Prasanchit","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11764-017-0606-3","article-title":"A Pilot Randomized Trial to Prevent Sexual Dysfunction in Postmenopausal Breast Cancer Survivors Starting Adjuvant Aromatase Inhibitor Therapy","volume":"11","author":"Advani","year":"2017","journal-title":"J. Cancer Surviv."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s11912-024-01633-3","article-title":"Effectiveness of Pelvic Floor Muscle and Education-Based Therapies on Bladder, Bowel, Vaginal, Sexual, Psychological Function, Quality of Life, and Pelvic Floor Muscle Function in Females Treated for Breast Cancer: A Systematic Review","volume":"27","author":"Cyr","year":"2025","journal-title":"Curr. Oncol. Rep."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Lubi\u00e1n-L\u00f3pez, D.M., Butr\u00f3n-Hinojo, C.A., Menj\u00f3n-Beltr\u00e1n, S., Gonz\u00e1lez-Mesa, E., Tapiador-Albertos, S., Rodr\u00edguez-Jim\u00e9nez, B., and Fiol-Ruiz, G. (2023). Effects of Non-Ablative Solid-State Vaginal Laser (SSVL) for the Treatment of Vulvovaginal Atrophy in Breast Cancer Survivors after Adjuvant Aromatase Inhibitor Therapy: Preliminary Results. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175669"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"102624","DOI":"10.1016\/j.ctrv.2023.102624","article-title":"Estrogen Deprivation Effects of Endocrine Therapy in Breast Cancer Patients: Incidence, Management and Outcome","volume":"120","author":"Cucciniello","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejca.2018.06.009","article-title":"Prevalence and Risk Factors for Fatigue among Breast Cancer Survivors on Aromatase Inhibitors","volume":"101","author":"Mao","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1002\/cncr.30815","article-title":"The Efficacy of Internet-based Cognitive Behavioral Therapy for Severely Fatigued Survivors of Breast Cancer Compared with Care as Usual: A Randomized Controlled Trial","volume":"123","author":"Abrahams","year":"2017","journal-title":"Cancer"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clbc.2016.07.003","article-title":"Cardiotoxicity of Aromatase Inhibitors in Breast Cancer Patients","volume":"17","author":"Foglietta","year":"2017","journal-title":"Clin. Breast Cancer"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"k3845","DOI":"10.1136\/bmj.k3845","article-title":"Long Term Adjuvant Endocrine Therapy and Risk of Cardiovascular Disease in Female Breast Cancer Survivors: Systematic Review","volume":"363","author":"Matthews","year":"2018","journal-title":"BMJ"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3390\/curroncol30020142","article-title":"Risk of Cardiovascular Events and Lipid Profile Change in Patients with Breast Cancer Taking Aromatase Inhibitor: A Systematic Review and Meta-Analysis","volume":"30","author":"Yoo","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.breast.2021.07.004","article-title":"Aromatase Inhibitors Use and Risk for Cardiovascular Disease in Breast Cancer Patients: A Population-Based Cohort Study","volume":"59","author":"Sund","year":"2021","journal-title":"Breast"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.119.044750","article-title":"Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer","volume":"141","author":"Filion","year":"2020","journal-title":"Circulation"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0959-8049(01)00155-1","article-title":"Effect of Letrozole on the Lipid Profile in Postmenopausal Women with Breast Cancer","volume":"37","author":"Elisaf","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1161\/01.CIR.96.6.1953","article-title":"Amelioration of Ischemia- and Reperfusion-Induced Myocardial Injury by 17\u03b2-Estradiol","volume":"96","author":"Node","year":"1997","journal-title":"Circulation"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"C57","DOI":"10.1152\/ajpcell.00414.2004","article-title":"Acute Effects of 17\u03b2-Estradiol on Myocardial PH, Na+, and Ca2+ and Ischemia-Reperfusion Injury","volume":"288","author":"Anderson","year":"2005","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40959-025-00352-3","article-title":"Atrial Fibrillation in Breast Cancer Therapy: Does Tamoxifen Confer a Lower Risk than Aromatase Inhibitors?","volume":"11","author":"Kwaah","year":"2025","journal-title":"Cardio-Oncology"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jacasi.2023.09.014","article-title":"Aromatase Inhibitor Therapy Increases the Risk of New-Onset Atrial Fibrillation in Patients With Breast Cancer","volume":"4","author":"Ho","year":"2024","journal-title":"JACC Asia"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/09537104.2018.1499885","article-title":"Novara Atherosclerosis Study Group (NAS) Impact of Metabolic Syndrome on Mean Platelet Volume and Its Relationship with Coronary Artery Disease","volume":"30","author":"Nardin","year":"2019","journal-title":"Platelets"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.diabres.2013.12.020","article-title":"Diabetes, Glucose Control and Mean Platelet Volume: A Single-Centre Cohort Study","volume":"104","author":"Verdoia","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-023-06997-x","article-title":"Development of Cardiometabolic Risk Factors Following Endocrine Therapy in Women with Breast Cancer","volume":"201","author":"Kwan","year":"2023","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.ejca.2007.08.029","article-title":"Effects of Third Generation Aromatase Inhibitors on Bone Health and Other Safety Parameters: Results of an Open, Randomised, Multi-Centre Study of Letrozole, Exemestane and Anastrozole in Healthy Postmenopausal Women","volume":"43","author":"McCloskey","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaccao.2024.08.006","article-title":"Cardiovascular Disease With Hormone Therapy and Ovarian Suppression in Premenopausal Breast Cancer Survivors","volume":"6","author":"Polter","year":"2024","journal-title":"JACC CardioOncol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on Cardio-Oncology Developed in Collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","article-title":"Long-Term Secondary Prevention of Cardiovascular Disease with a Mediterranean Diet and a Low-Fat Diet (CORDIOPREV): A Randomised Controlled Trial","volume":"399","author":"Fuentes","year":"2022","journal-title":"Lancet"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.hroo.2024.11.023","article-title":"Local Epicardial Robotic-Enhanced Hybrid Ablation Efficacy Predictors for Persistent Atrial Fibrillation","volume":"6","author":"Celentano","year":"2025","journal-title":"Hear. Rhythm O2"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/03008916231216830","article-title":"Adjuvant Treatment in Hormone Receptor-Positive Early Breast Cancer: New Approaches of Endocrine Therapy","volume":"110","author":"Nardin","year":"2024","journal-title":"Tumori J."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1093\/eurheartj\/ehae556","article-title":"A Focus on Two Rapidly Expanding Fields: Cardio-Oncology and Genetics","volume":"45","author":"Crea","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1158\/1078-0432.CCR-23-1568","article-title":"SNP of Aromatase Predict Long-Term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials","volume":"29","author":"Conte","year":"2023","journal-title":"Clin. Cancer Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2726\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:33:44Z","timestamp":1760034824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":182,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cancers17172726"],"URL":"https:\/\/doi.org\/10.3390\/cancers17172726","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}